Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
42.98
0.81 (1.92%)
At close: Aug 15, 2025, 2:33 PM
Supernus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 64.5M | 61.91M | 73.86M | 59.71M | 5.24M | -15.51M | 1.32M | 25.62M | 43.35M | 52.04M | 60.71M | 37.67M | 57.48M | 73.35M | 53.42M | 81.75M | 100.19M | 111.13M |
Depreciation & Amortization | 80.64M | 80.02M | 80.39M | 83.22M | 84.99M | 85.01M | 84.86M | 84.03M | 83.95M | 84.78M | 85.54M | 77.4M | 62.3M | 47.37M | 32.59M | 25.41M | 26.31M | 23M |
Stock-Based Compensation | 30.88M | 29.93M | 27.75M | 26.57M | 26.81M | 26.35M | 26.76M | 24.57M | 21.64M | 19.85M | 17.57M | 17.34M | 16.39M | 17.56M | 17.91M | 17M | 17.46M | 16.94M |
Other Working Capital | -1.9M | -1.56M | -4.92M | 5.91M | 47.71M | 11.86M | -3.14M | -348K | -20.46M | 13.15M | 29.14M | 30.34M | -20.5M | 346K | -3.9M | -19.37M | -23.7M | -11.25M |
Other Non-Cash Items | 23.86M | 72.43M | 110.59M | 126.93M | 126.99M | 74.93M | 33M | 10.65M | 21.32M | 14.42M | 2.16M | 5.68M | -13K | -4.53M | 24.62M | 25.5M | 18.71M | 25.48M |
Deferred Income Tax | -17.69M | -18.64M | -20.14M | -30.52M | -33.32M | -30.76M | -25.71M | -23.02M | -16.26M | -13.75M | -26.32M | -23.08M | -19M | -15.44M | -4.99M | 369K | 1.58M | -2.54M |
Change in Working Capital | 12.38M | -2.01M | -2.05M | 5.05M | 42.61M | -690K | -9.14M | -28.18M | -82.34M | 2.89M | -24.24M | 21.59M | 1.51M | -23.07M | 3.57M | -39.73M | -44.24M | -8.33M |
Operating Cash Flow | 187.06M | 164.15M | 171.95M | 172.5M | 154.86M | 100.36M | 111.08M | 93.69M | 71.66M | 161.65M | 116.83M | 138.03M | 120.07M | 95.23M | 127.13M | 110.3M | 120.01M | 165.68M |
Capital Expenditures | -1.2M | -804K | -725K | -476K | -426K | -521K | -551K | 274K | 277K | 1.01M | 439K | -462K | -812K | -1.39M | -2.04M | -2.22M | -1.89M | -2.42M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 82.08M | 82.08M | 82.08M | -228.66M | -310.74M | -311.69M | -311.69M | -2.29M | -2.29M | -298.54M |
Purchase of Investments | -629.45M | -612.87M | -688.01M | -644.23M | -419.3M | -295.32M | -101.62M | -66.33M | -200.49M | -308.93M | -406.99M | -344.6M | -284.8M | -290.57M | -311.57M | -315.63M | -313.78M | -199.57M |
Sales Maturities Of Investments | 547.69M | 512.74M | 498.86M | 401.49M | 288.16M | 273.17M | 370.9M | 352.85M | 370.14M | 401.87M | 190.74M | 551.15M | 567.78M | 509.86M | 530.51M | 211.55M | 204.33M | 374.64M |
Other Investing Acitivies | 9K | -48.52M | -99.9M | -99.9M | -65.12M | 43.86M | 335.3M | 334.45M | 217.58M | 140.87M | -168.33M | -154.59M | -72.05M | -56.74M | 11.94M | -1.05M | -1.62M | -312.89M |
Investing Cash Flow | -82.94M | -100.93M | -189.87M | -243.21M | -131.56M | -22.68M | 268.73M | 285.94M | 169.08M | 93.1M | -216.66M | -91.77M | -15.24M | -80.45M | -81.91M | -108.7M | -114.3M | -141.58M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -480.86M | -402.5M | -402.5M | -402.5M | 78.36M | n/a | n/a | n/a | n/a | n/a | 254K | 254K | 254K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -27.16M | -24.82M | -2.71M | -3.72M | -3.33M | -3.9M | -3.01M | -1.02M | -1.02M | -445K | -22.9M | -161.22M | -159.89M | -159.89M | -136.99M | 1.32M | -1.06M | -1.06M |
Financial Cash Flow | -11.5M | -10.78M | 12.19M | 7.39M | 4.09M | -476.48M | -397.88M | -396.14M | -389.46M | 91.73M | -10.48M | -150.05M | -155.18M | -154.7M | -130.42M | 9.39M | 7.09M | 5.77M |
Net Cash Flow | 92.62M | 52.45M | -5.72M | -63.31M | 27.38M | -398.8M | -18.07M | -16.51M | -148.72M | 346.49M | -110.31M | -103.79M | -50.34M | -139.93M | -85.21M | 10.99M | 12.8M | 29.88M |
Free Cash Flow | 185.87M | 163.34M | 171.23M | 172.03M | 154.43M | 99.84M | 110.53M | 93.97M | 71.93M | 162.66M | 117.27M | 137.56M | 119.26M | 93.84M | 125.08M | 108.08M | 118.12M | 163.26M |